Free Trial

Precigen (PGEN) Insider Trading & Ownership

$1.00
-0.08 (-7.44%)
(As of 09/20/2024 ET)

Precigen (NASDAQ:PGEN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
44.90%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$221,576.81
Number Of
Insiders Selling
(Last 12 Months)
0
Get PGEN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Precigen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PGEN Insider Buying and Selling by Quarter

Precigen Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2024Jeffrey Thomas PerezSVPBuy58,823$0.85$49,999.55  
12/28/2023Randal J KirkDirectorBuy96,686$1.41$136,327.26  
9/22/2023Dean J MitchellDirectorBuy25,000$1.41$35,250.00  
(Data available from 1/1/2013 forward)

PGEN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Precigen includes Dean J Mitchell, Donald P Lehr, Harry Jr. Thomasian, Helen Sabzevari, Jeffrey B Kindler, Jeffrey Thomas Perez, Randal J Kirk, Rutul R Shah, Steven Frank, and Trading S.A. Ares. Learn more on insiders at PGEN.

44.90% of Precigen stock is owned by insiders. Learn more on PGEN's insider holdings.

The following insiders have purchased PGEN shares in the last 24 months: Dean J Mitchell ($35,250.00), Helen Sabzevari ($39,999.75), Jeffrey Thomas Perez ($99,998.80), Randal J Kirk ($20,316,637.12), Rutul R Shah ($15,998.50), and Steven Frank ($688,000.00).

Insiders have purchased a total of 12,189,061 PGEN shares in the last 24 months for a total of $21,195,884.17 bought.

The following insiders have sold PGEN shares in the last 24 months: Donald P Lehr ($60,960.84), Harry Jr. Thomasian ($44,977.67), Helen Sabzevari ($328,306.71), Jeffrey Thomas Perez ($49,513.35), and Rutul R Shah ($30,010.91).

Insiders have sold a total of 359,020 Precigen shares in the last 24 months for a total of $513,769.48 sold.

Precigen Key Executives



This page (NASDAQ:PGEN) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners